- Home
- KSCP vs TPST Comparison
KSCP vs TPST Comparison
Compare KSCP & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- TPST
- Stock Information
- Founded
- KSCP 2013
- TPST 2011
- Country
- KSCP United States
- TPST United States
- Employees
- KSCP N/A
- TPST N/A
- Industry
- KSCP Telecommunications Equipment
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- KSCP Telecommunications
- TPST Health Care
- Exchange
- KSCP Nasdaq
- TPST Nasdaq
- Market Cap
- KSCP 29.3M
- TPST 33.0M
- IPO Year
- KSCP 2022
- TPST N/A
- Fundamental
- Price
- KSCP $6.87
- TPST $7.40
- Analyst Decision
- KSCP Strong Buy
- TPST Hold
- Analyst Count
- KSCP 3
- TPST 3
- Target Price
- KSCP $15.67
- TPST $30.00
- AVG Volume (30 Days)
- KSCP 274.1K
- TPST 241.4K
- Earning Date
- KSCP 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- KSCP N/A
- TPST N/A
- EPS Growth
- KSCP N/A
- TPST N/A
- EPS
- KSCP N/A
- TPST N/A
- Revenue
- KSCP $11,468,000.00
- TPST N/A
- Revenue This Year
- KSCP $16.17
- TPST N/A
- Revenue Next Year
- KSCP $39.02
- TPST N/A
- P/E Ratio
- KSCP N/A
- TPST N/A
- Revenue Growth
- KSCP N/A
- TPST N/A
- 52 Week Low
- KSCP $2.45
- TPST $5.35
- 52 Week High
- KSCP $28.57
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- KSCP 68.62
- TPST 53.40
- Support Level
- KSCP $4.74
- TPST $7.06
- Resistance Level
- KSCP $5.18
- TPST $7.18
- Average True Range (ATR)
- KSCP 0.40
- TPST 0.26
- MACD
- KSCP 0.15
- TPST 0.02
- Stochastic Oscillator
- KSCP 77.62
- TPST 90.05
About KSCP Knightscope Inc.
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.